Home › NDC Lookup › RxCUI directory › RxCUI 313595

Verteporfin 15 MG Injection — RxCUI 313595

Name: Verteporfin 15 MG Injection (RxCUI 313595)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 313595 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI313595

Official nameVerteporfin 15 MG Injection

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

FDA products mapped2

Package NDCs mapped2

Reported Medicaid activity (SDUD)25 prescriptions · 2 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Verteporfin Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Visudyne is a completely different kind of treatment — it's not something you take at home. It's given through an IV in a clinical setting, and the drug itself only becomes active...
What exactly is this treatment, and how is it different from regular eye drops or pills?
After the infusion, verteporfin is still circulating in your skin and other tissues. Any bright light — including sunlight or strong indoor lighting — can activate it and cause a s...
Why do I have to avoid sunlight for 5 days after the injection?

📖 Read our full Verteporfin Injection guide →

🕸️ Concept Web — How Verteporfin 15 MG Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Verteporfin 15 MG Injection RxCUI 313595 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Verteporfin 118886 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Visudyne 261696 BN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Verteporfin Injection 1867718 SCDF
- Verteporfin Injectable Product 1160514 SCDG
- Verteporfin Injection [Visudyne] 1867721 SBDF
- Visudyne Injectable Product 1187180 SBDG
- Injection 1649574 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Verteporfin 15 MG 1867717 SCDC
- Verteporfin 15 MG Injection [Visudyne] 351914 SBD
- Verteporfin 15 MG [Visudyne] 1867720 SBDC

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Verteporfin 15 MG SCDC · 1867717
Verteporfin Injection SCDF · 1867718
Verteporfin Injectable Product SCDG · 1160514

Brand-Name Concepts

Verteporfin 15 MG Injection [Visudyne] SBD · 351914
Verteporfin 15 MG [Visudyne] SBDC · 1867720
Verteporfin Injection [Visudyne] SBDF · 1867721
Visudyne Injectable Product SBDG · 1187180
Visudyne BN · 261696

📦 FDA Products & Package NDCs

2 products · 2 package NDCs

2 package NDCs map to RxCUI 313595 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00187-5600-15	1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (...	Visudyne	Bausch Health US LLC	2000-04-12
24208-0560-15	1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (...	Visudyne	Bausch & Lomb Incorporated	2023-02-27

Observed labelers: Bausch & Lomb Incorporated (1) · Bausch Health US LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J3396	Verteporfin injection	2	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.